[(E,2R,3S)-1,3-dihydroxyoctadec-4-en-2-yl]-trimethylazanium
C21H44NO2+ — CID 124542759
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(E,2R,3S)-1,3-dihydroxyoctadec-4-en-2-yl]-trimethylazanium
[(E,2R,3S)-1,3-dihydroxyoctadec-4-en-2-yl]-trimethylazanium (PubChem CID 124542759) has the molecular formula C21H44NO2+ and a molecular weight of 342.59 g/mol. Its IUPAC name is [(E,2R,3S)-1,3-dihydroxyoctadec-4-en-2-yl]-trimethylazanium.
Molecular Properties
| Compound Name | [(E,2R,3S)-1,3-dihydroxyoctadec-4-en-2-yl]-trimethylazanium |
|---|---|
| PubChem CID | 124542759 |
| Molecular Formula | C21H44NO2+ |
| Molecular Weight | 342.59 g/mol |
| Exact Mass | 342.34 |
| IUPAC Name | [(E,2R,3S)-1,3-dihydroxyoctadec-4-en-2-yl]-trimethylazanium |
| SMILES | CCCCCCCCCCCCC/C=C/[C@H](O)[C@@H](CO)[N+](C)(C)C |
| InChI | InChI=1S/C21H44NO2/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-21(24)20(19-23)22(2,3)4/h17-18,20-21,23-24H,5-16,19H2,1-4H3/q+1/b18-17+/t20-,21+/m1/s1 |
| InChIKey | XOKJULOVXVISRP-JGDRDZSESA-N |
| XLogP | 4.67 |
| TPSA | 40.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 342.59 |
| LogP ≤ 5 | 4.67 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 124542759 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.